INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Systematic review / meta-analysis / 2016

Niacin therapy is associated with a moderately increased risk of new-onset diabetes in randomized controlled trials.

A meta-analysis of 11 randomized controlled trials evaluated the link between niacin therapy and new-onset diabetes in 26,340 non-diabetic participants over a weighted mean follow-up of 3.6 years. In total, 1,371 participants developed diabetes (725 of 13,121 assigned to niacin vs 646 of 13,219 controls). Niacin was associated with a significantly higher risk of new-onset diabetes (RR 1.34, 95% CI 1.21 to 1.49; I2 = 0.0%), equating to one extra diabetes case per 43 participants treated for 5 years. Results remained consistent regardless of background statin therapy (p = 0.88) or combination with laropiprant (p = 0.52).

Study type
Meta-analysis of randomized controlled trials
Who was studied
26,340 non-diabetic participants across 11 trials
What was measured
New-onset diabetes

THE PAPER

Niacin therapy and the risk of new-onset diabetes: a meta-analysis of randomised controlled trials.

Goldie C, Taylor AJ, Nguyen P, McCoy C, Zhao XQ, Preiss D. Heart, 2016.

PubMed 26370223 ↗DOI 10.1002/clc.4960260304 ↗

Heart & arteriesDiabetes & blood sugarNutrients & adequacy

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.